Bone Marrow TransplantationTransplantation, HomologousBone MarrowHematopoiesisHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseStem CellsHematopoietic Stem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationTissue DonorsGraft SurvivalAnemia, AplasticLeukemiaBone and BonesTransplantation ChimeraHematologic NeoplasmsHistocompatibility TestingBusulfanHematopoiesis, ExtramedullaryHistocompatibilityKidney TransplantationBone Marrow PurgingLiver TransplantationTreatment OutcomeTransplantationImmunosuppressive AgentsRecurrenceCyclophosphamideTime FactorsCytomegalovirus InfectionsCombined Modality TherapyCell DifferentiationMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionTransplantation, IsogeneicLeukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseRetrospective StudiesPeripheral Blood Stem Cell TransplantationBone Marrow DiseasesColony-Forming Units AssayImmunocompromised HostPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHematologic DiseasesRadiation ChimeraImmunosuppressionAcute DiseaseOpportunistic InfectionsEmbryonic Stem CellsLeukemia, MyeloidHeart TransplantationAntigens, CD34Lymphocyte DepletionSurvival AnalysisLeukocyte TransfusionTransplantation ImmunologyMyelodysplastic SyndromesLymphoma, Non-HodgkinCyclosporineBone Marrow ExaminationCells, CulturedHematopoietic Stem Cell MobilizationT-LymphocytesHLA AntigensAdult Stem CellsFlow CytometryCell LineageMultiple MyelomaLung TransplantationGranulocyte Colony-Stimulating FactorSurvival RateMesenchymal Stem Cell TransplantationChimeraAntineoplastic Combined Chemotherapy ProtocolsBone RemodelingFollow-Up StudiesBone Marrow NeoplasmsFatal OutcomeGraft vs Host ReactionCord Blood Stem Cell TransplantationOrgan TransplantationGraft vs Leukemia EffectAspergillosisMelphalanSevere Combined ImmunodeficiencyMycosesStem Cell NicheStem Cell FactorDisease-Free SurvivalCell TransplantationCytomegalovirusPluripotent Stem CellsTransplantsChimerism